RIKEN Center for Brain Science
Recruitment of new faculty positions (Principal Investigator position)
The RIKEN Center for Brain Science (CBS) is Japan's premier neuroscience research center that builds on the twenty years of research achievements of its predecessor, the RIKEN Brain Science Institute (BSI). Taking advantage of the multidisciplinarity of the fields of medicine, biology, chemistry, engineering, mathematical sciences, and psychology, our aim is to advance basic research on the functions of the brain and the mind—from the levels of single cells and whole organisms to societal systems—and develop innovative technologies in the process. We also aim to find solutions to the issues confronting contemporary society, as we grapple with the psychological ramifications of our own inventions such as artificial intelligence (AI) and big data, and as we seek to conquer diseases such as depression and dementia.
For details, please refer to the RIKEN CBS website. https://cbs.riken.jp/en/
Now we are newly seeking outstanding neuroscientists for tenure-track Team Leader positions (equivalent to U.S. Assistant or Associate Professors). However, exceptional applications from internationally established neuroscientists may be considered for tenured Team Leader positions (equivalent to U.S. Full Professors). This is our first round of faculty recruitment at CBS, and in the coming several years CBS plans to open approximately 10 new Team Leader positions for outstanding neuroscientists.
Required documents (All documents including letters of recommendation should be written in English)
1. A cover letter with a brief summary of the current research program and future plan
2. Complete CV (with photo, home address, telephone number, email address, work history, academic degrees, current affiliation and position, certifications, etc.) Please write the number (W18032) next to the title of this job posting in the upper right corner of your CV.
3. List of research achievements and publications (separate by category: research papers, review papers, patents, etc.)
4. Current research and achievements to date
5. Future research plans
6. Reprints of major research papers you authored (maximum five papers); circle these paper titles in the list of research achievement and publications above (item 3).
7. Three letters of recommendation (including one from the current supervisor, if available.) Please arrange to have the recommendation letters sent directly from referees to the CBS Search Committee address (see below) as a PDF document prepared as follows:
NB1: Letters of recommendation must be signed (or stamped) by the person writing the letter.
NB2: Letters must be addressed to “Director Yasushi Miyashita, RIKEN Center for Brain Science”.
NB3: If current supervisor's recommendation is not available, a recommendation letter from a third party will be accepted.
NB4: The applicant should inform us (CBS Search Committee) of the referee's title and position, affiliation, telephone number, email address and relationship between the applicant.
In addition to the items 1 to 7 above, during the hiring procedures for successful candidates, a check sheet and a Confirmation of employment duration and duties form and documents for obtaining a work visa for non-Japanese nationals will be required.
RIKEN CBS is located just outside of the international metropolis of Tokyo. English is the primary language used in activities at CBS, including seminars and administration. Institutional support is available to help non-Japanese speaking scientists, whom we particularly encourage to apply. RIKEN Center for Brain Science is an Equal Opportunity Employer. Women are strongly encouraged to apply.
A postdoctoral position is open in the area of molecular pathogenesis of age-related diseases at Northwestern University School of Medicine in Chicago, USA. [Yuasa-Kawada et al, Nature Neuroscience 12:1087-1089; Yuasa-Kawada et al., Proc Natl Acad Sci USA 106:14530-14535; Li et al, Proc Natl Acad Sci USA 107:3169-3174; Guo W, et al, Nature Structural & Mol Biol 18:822–830; Zhu et al., Hum Mol Genet. 23(25):6863-77; Deng et al., PloSGenetics 2015 Sep 3;11(9):e1005357; Kong et al., J Clinical Investigation 125(12):4407-4420; Deng J et al, 2018, Proc Natl Acad Sci USA In press].